Inventor
Jan Vilcek
Inventor
New York, NY, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
7,744,885'Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof'20107,425,330'Methods of inhibiting TNFα activity in the blood of a patient'20087,416,729'Methods of treating rheumatoid arthritis with anti-TNF antibodies'20087,404,955'Methods of inhibiting or neutralizing TNFα in patients with tissue injury'20087,374,761'Recombinant A2-specific TNFα-specific antibodies'20087,335,358'Methods of treating psoriasis with anti-TNF antibodies'20087,276,239'Recombinant A2-specific TNFα-specific antibodies'20077,252,823'Recombinant A2-specific TNFα-specific antibodies'20077,226,593'Methods of treating cachexia with chimeric anti-TNF antibodies'20077,227,003'Anti-TNF antibody fragments'20077,223,396'Methods of treatment of fistulas in Crohn\'s disease with anti-TNF antibodies'20077,214,376'Methods of inhibiting TNFα in patients with neoplastic disease'20077,204,985'Methods of treating disseminated intravascular coagulation by multiple administration of anti-TNF antibodies'20077,192,584'Methods of treating psoriasis with anti-TNF antibodies'20077,179,893'Recombinant anti-TNF-α antibodies'20077,179,466'Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies'20077,169,388'Methods of inhibiting TNFα in patients with cancer'20077,169,386'Methods of treating inflammation associated with viral infection with anti-TNF antibodies'20077,166,284'Methods of treating joint inflammation with anti-TNF antibodies'20077,160,995'DNA encoding anti-TNF antibodies and peptides'20077,160,542'Method of treating psoriasis using human anti-TNF antibodies and fragments'20077,160,543'Methods of inhibiting TNF-α in patients with Crohn\'s disease'20077,138,118'Methods of treating rheumatoid arthritis with anti-TNF antibodies'20067,135,178'Methods of treating disseminated intravascular coagulation using anti-TNF antibodies'20067,135,179'Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof'20067,128,907'Methods of treating crohn\'s disease with anti-TNF antibodies'20067,128,908'Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof'20067,101,674'Anti-idiotypic anti-TNF antibodies and related immunoassay methods'20067,070,775'Recombinant A2-specific TNFα specific antibodies'20066,991,791'Anti-TNF antibodies and peptides of human tumor necrosis factor'20066,835,823'Anti-TNF antibodies and peptides of human tumor necrosis factor'20046,790,444'Anti-TNF antibodies and peptides of human necrosis factor'20046,518,401'Tumor necrosis factor stimulated gene 6 (TSG-6) protein'20036,313,091'Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method'20016,284,471'Anti-TNFa antibodies and assays employing anti-TNFa antibodies'20016,277,969'Anti-TNF antibodies and peptides of human tumor necrosis factor'20016,210,905'Tumor necrosis factor stimulated gene 6 (TSG-6) binding molecules'20015,919,452'Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies'19995,846,763'DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6)'19985,698,195'Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies'19975,656,272'Methods of treating TNF-.alpha.-mediated Crohn\'s disease using chimeric anti-TNF antibodies'19975,426,181'DNA encoding cytokine-induced protein, TSG-14'19955,386,013'Tumor necrosis factor-induced protein TSG-6'19954,835,256'Human gamma interferon polypeptide having glutamine as the ninth n-terminal amino acid'19894,666,865'Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies'19874,460,685'Method of enhancing the production of human .gamma. Interferon'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–2010Patents assigned to UNIV NEW YORK (28)· patent assignee history
1984–2010Based in New York, NY, US· patent location history
1987–2010Patents assigned to CENTOCOR INC (27)· patent assignee history
1989Patents assigned to JAPAN FOUND CANCER (1)· patent assignee history
1989Patents assigned to NEW YORK UNIVERSITY & JURIDICA (1)· patent assignee history
1997–2004Patents assigned to UNIV NEW YORK MED CT (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV NEW YORK | 28 | 1984–2010 |
| CENTOCOR INC | 27 | 1987–2010 |
| UNIV NEW YORK MED CT | 4 | 1997–2004 |
| JAPAN FOUND CANCER | 1 | 1989 |
| NEW YORK UNIVERSITY & JURIDICA | 1 | 1989 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 46 | 1984–2010 |